Cargando…

Pan-Cancer Analysis of the Oncogenic and Immunological Role of RCN3: A Potential Biomarker for Prognosis and Immunotherapy

Despite emerging publications have elucidated a functional association between RCN3 and tumors, no evidence about a pan-cancer analysis of RCN3 is available. Our study first conducted a comprehensive assessment of its expression profiles, prognosis value, immune infiltration, and relevant cellular p...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ding, Jian, Meng, Yan, Han, Zelong, Luo, Xiaobei, Guo, Xuxue, Li, Yiwen, Liu, Side, Zhuang, Kangmin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9149440/ https://www.ncbi.nlm.nih.gov/pubmed/35651805 http://dx.doi.org/10.3389/fonc.2022.811567

Ejemplares similares

Comprehensive analysis of the prognosis and immune effect of the oncogenic protein Four Jointed Box 1
por: Huang, Mei, et al.
Publicado: (2023)

A pan-cancer analysis of thioredoxin-interacting protein as an immunological and prognostic biomarker
por: Guo, Xuxue, et al.
Publicado: (2022)

YTHDF1 Is a Potential Pan-Cancer Biomarker for Prognosis and Immunotherapy
por: Hu, Jian, et al.
Publicado: (2021)

Comprehensive analysis of the potential cuproptosis-related biomarker LIAS that regulates prognosis and immunotherapy of pan-cancers
por: Cai, Yuan, et al.
Publicado: (2022)

Comprehensive Analysis of the Oncogenic, Genomic Alteration, and Immunological Landscape of Cation-Chloride Cotransporters in Pan-Cancer
por: Wang, Jie, et al.
Publicado: (2022)

Pan-cancer analysis of the prognostic and immunological role of GJB2: a potential target for survival and immunotherapy
por: Jia, Yuting, et al.
Publicado: (2023)

Systematic pan-cancer analysis identifies gasdermin B as an immunological and prognostic biomarker for kidney renal clear cell carcinoma
por: Liu, Xuehe, et al.
Publicado: (2023)

Pan-cancer analysis of kinesin family members with potential implications in prognosis and immunological role in human cancer
por: Zhong, Ming, et al.
Publicado: (2023)

Pan-cancer analyses identify DCBLD2 as an oncogenic, immunological, and prognostic biomarker
por: Xie, Pan, et al.
Publicado: (2022)

A Pan-Cancer Analysis of the Oncogenic Role of BCL7B: A Potential Biomarker for Prognosis and Immunotherapy
por: Yang, Dinglong, et al.
Publicado: (2022)

Pan-Cancer Analysis of the Mitophagy-Related Protein PINK1 as a Biomarker for the Immunological and Prognostic Role
por: Zhu, Lizhe, et al.
Publicado: (2020)

Pan-cancer analysis identifies LIFR as a prognostic and immunological biomarker for uterine corpus endometrial carcinoma
por: Zhang, Fang, et al.
Publicado: (2023)

RCN2 promotes Nasopharyngeal carcinoma progression by curbing Calcium flow and Mitochondrial apoptosis
por: Yao, Hui, et al.
Publicado: (2023)

Identification and Validation of a Novel Prognostic Gene Model for Colorectal Cancer
por: Meng, Yan, et al.
Publicado: (2022)

FAIM2 is a potential pan-cancer biomarker for prognosis and immune infiltration
por: Cai, Jiayang, et al.
Publicado: (2022)

Rcn3 Suppression Was Responsible for Partial Relief of Emphysema as Shown by Specific Type II Alveolar Epithelial Cell Rcn3 CKO Mouse Model
por: Zhang, Qianyu, et al.
Publicado: (2021)

The role of TGR5 as an onco-immunological biomarker in tumor staging and prognosis by encompassing the tumor microenvironment
por: Guan, Zhiyuan, et al.
Publicado: (2022)

Prognostic and Immunological Role of Gasdermin E in Pan-Cancer Analysis
por: Zhang, Zheng, et al.
Publicado: (2021)

Comprehensive prognostic and immunological analysis of CCT2 in pan-cancer
por: Lv, Wenming, et al.
Publicado: (2022)

Rare coding variants in RCN3 are associated with blood pressure
por: He, Karen Y., et al.
Publicado: (2022)

ZCCHC17 Served as a Predictive Biomarker for Prognosis and Immunotherapy in Hepatocellular Carcinoma
por: Liu, Fahui, et al.
Publicado: (2022)

Comprehensive Pan-Cancer Analysis of GINS2 for Human Tumour Prognosis and as an Immunological Biomarker
por: Meng, Wei, et al.
Publicado: (2022)

Pan-Cancer Analysis of IGF-1 and IGF-1R as Potential Prognostic Biomarkers and Immunotherapy Targets
por: Zhang, Yinqi, et al.
Publicado: (2021)

Lipid metabolism in tumor immunology and immunotherapy
por: Duong, Lisa K., et al.
Publicado: (2023)

Editorial: Immunotherapy for NSCLC with oncogenic driver variants
por: Du, Yijia, et al.
Publicado: (2022)

DEF6 has potential to be a biomarker for cancer prognosis: A pan-cancer analysis
por: Yuan, Ziming, et al.
Publicado: (2023)

A pan-cancer analysis of ABI3BP: a potential biomarker for prognosis and immunoinfiltration
por: Feng, Yan, et al.
Publicado: (2023)

Pan-Cancer Analyses Reveal Oncogenic Role and Prognostic Value of F-Box Only Protein 22
por: Chen, Sen, et al.
Publicado: (2022)

Editorial: Immunology and Immunotherapy of Head and Neck Cancer
por: Gavrielatou, Niki, et al.
Publicado: (2021)

Editorial: Advancements in immunology and immunotherapy for breast cancer
por: Sugie, Tomoharu, et al.
Publicado: (2022)

Pan-cancer analysis reveals DDX21 as a potential biomarker for the prognosis of multiple tumor types
por: Hu, Ankang, et al.
Publicado: (2022)

Pan-cancer analysis and in vitro validation of the oncogenic and prognostic roles of AURKA in human cancers
por: Yang, Chuang, et al.
Publicado: (2023)

KIF20A promotes cellular malignant behavior and enhances resistance to chemotherapy in colorectal cancer through regulation of the JAK/STAT3 signaling pathway
por: Xiong, Man, et al.
Publicado: (2019)

Pan-Cancer Analyses Reveal Oncogenic and Immunological Role of PLOD2
por: Xu, Qiqi, et al.
Publicado: (2022)

CDK5 functions as a tumor promoter in human colorectal cancer via modulating the ERK5–AP-1 axis
por: Zhuang, Kangmin, et al.
Publicado: (2016)

Editorial: Advances in Head and Neck Cancer Immunology and Immunotherapy
por: Abu Eid, Rasha
Publicado: (2019)

Editorial: New Insights into the Complexity of Tumor Immunology in B-cell Malignancies: Tumor Immunology and Immunotherapy
por: Seiffert, Martina, et al.
Publicado: (2022)

Integrative Analyses and Verification of the Expression and Prognostic Significance for RCN1 in Glioblastoma Multiforme
por: Lu, Weicheng, et al.
Publicado: (2021)

An Integrative Pan-Cancer Analysis Revealing LCN2 as an Oncogenic Immune Protein in Tumor Microenvironment
por: Xu, Wen-Xiu, et al.
Publicado: (2020)

A Pan-Cancer Analysis of the Oncogenic Role of Nuclear Transport Factor 2 in Human Cancers
por: Li, Yu, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_hq3tfkahm1ggh8e5j47gme0b0h